You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for HYDROCHLOROTHIAZIDE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HYDROCHLOROTHIAZIDE

Average Pharmacy Cost for HYDROCHLOROTHIAZIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HYDROCHLOROTHIAZIDE 12.5 MG CP 29300-0130-05 0.02926 EACH 2025-02-19
HYDROCHLOROTHIAZIDE 12.5 MG CP 29300-0130-10 0.02926 EACH 2025-02-19
HYDROCHLOROTHIAZIDE 12.5 MG CP 29300-0130-01 0.02926 EACH 2025-02-19
HYDROCHLOROTHIAZIDE 12.5 MG CP 50228-0146-01 0.02926 EACH 2025-02-19
HYDROCHLOROTHIAZIDE 12.5 MG CP 00591-0347-01 0.02926 EACH 2025-02-19
HYDROCHLOROTHIAZIDE 50 MG TAB 69584-0362-90 0.03450 EACH 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for HYDROCHLOROTHIAZIDE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
HYDROCHLOROTHIAZIDE 12.5MG CAP AvKare, LLC 69367-0219-05 500 19.91 0.03982 EACH 2023-06-15 - 2028-06-14 FSS
HYDROCHLOROTHIAZIDE 50MG TAB Golden State Medical Supply, Inc. 51407-0332-90 90 2.55 0.02833 EACH 2023-06-15 - 2028-06-14 FSS
HYDROCHLOROTHIAZIDE 12.5MG/IRBESARTAN 150MG T AvKare, LLC 00093-8238-98 90 29.52 0.32800 EACH 2023-06-15 - 2028-06-14 FSS
HYDROCHLOROTHIAZIDE 50MG/TRIAMTERENE 75MG TAB AvKare, LLC 60505-2657-05 500 130.52 0.26104 EACH 2023-06-15 - 2028-06-14 FSS
HYDROCHLOROTHIAZIDE 12.5MG/OLMESARTAN 20MG TA AvKare, LLC 42291-0924-90 90 372.79 4.14211 EACH 2024-02-15 - 2028-06-14 FSS
HYDROCHLOROTHIAZIDE 12.5MG TAB Golden State Medical Supply, Inc. 51407-0330-01 100 4.15 0.04150 EACH 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Hydrochlorothiazide

Introduction

Hydrochlorothiazide, a diuretic commonly used to treat hypertension, fluid retention, and other cardiovascular conditions, is a significant player in the global pharmaceutical market. This article delves into the market analysis, trends, and price projections for hydrochlorothiazide, providing insights into its current and future market dynamics.

Global Market Scope

The global hydrochlorothiazide market is expansive, covering various regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market is segmented by type (tablet, capsule, and liquid), application (hypertension, fluid retention, heart attack, kidney failure, and others), and end user (hospitals, drug stores, and others)[3][4].

Market Drivers

Several factors drive the growth of the hydrochlorothiazide market:

Increasing Prevalence of Hypertension

The rising prevalence of hypertension globally is a major driver. According to the World Health Organization (WHO), approximately 1.13 billion people suffer from hypertension, and this number is expected to increase to 29% by 2025, particularly in economically developing nations[3].

Growing Prevalence of Cardiovascular Diseases

The increasing incidence of coronary artery disease and other cardiovascular conditions also boosts the demand for hydrochlorothiazide. For instance, 18% of individuals worldwide suffer from coronary artery diseases, as reported by the Lancet[3].

Aging Population

An aging population contributes to the increased demand for hydrochlorothiazide, as older individuals are more prone to hypertension and other cardiovascular diseases.

Market Trends

Sales and Price Analysis

Historical data shows that hydrochlorothiazide sales have been steady, with significant sales recorded in countries across North America, Europe, Japan, BRIC, and Australia. The sales forecast until 2021 indicated a growth trend, with the global sales expected to continue rising due to increasing demand[2].

Generic Trends

The market is also influenced by the availability of generic versions of hydrochlorothiazide, which can impact pricing and market share. Generic versions often offer a more affordable alternative, which can drive sales volume but may reduce the average price per unit[2].

Price Projections

Current Pricing

The current prices of hydrochlorothiazide vary based on the dosage and quantity. For example, a 12.5 mg oral capsule can cost between $10.22 for 6 capsules to $69.91 for 500 capsules. Similarly, a 25 mg oral tablet can range from $9.61 for 7 tablets to $24.64 for 1000 tablets[5].

Future Pricing Trends

Given the increasing demand and the competitive nature of the market, prices are expected to remain relatively stable or see a slight decrease due to the presence of generics. However, fluctuations can occur due to factors such as stock shortages and changes in raw material costs.

"According to the report by Allied Market Research, the hydrochlorothiazide market forecast is studied from 2021 to 2030, indicating a positive growth trajectory driven by increasing prevalence of hypertension and other cardiovascular diseases"[3].

Regional Analysis

The market is geographically diverse, with significant sales in various regions:

North America and Europe

These regions have a well-established market for hydrochlorothiazide, driven by high healthcare spending and a large patient population suffering from hypertension and other cardiovascular conditions[2].

Asia Pacific

This region is expected to see significant growth due to the increasing prevalence of hypertension and cardiovascular diseases, coupled with improving healthcare infrastructure and rising healthcare expenditure[4].

Competitive Analysis

The hydrochlorothiazide market is highly competitive, with several key players operating globally. The competition is further intensified by the presence of generic versions, which can erode the market share of branded products. Companies must focus on strategic positioning, competitive pricing, and innovative marketing to maintain their market share[4].

Market Forecast

The global hydrochlorothiazide market is forecasted to grow at a compound annual growth rate (CAGR) from 2024 to 2031. The market size is expected to increase significantly, driven by the factors mentioned above. The forecast period from 2024 to 2031 will see continued growth, with the market size reaching new highs due to the increasing demand for hydrochlorothiazide[1][4].

Key Takeaways

  • The global hydrochlorothiazide market is driven by the increasing prevalence of hypertension and other cardiovascular diseases.
  • The market is segmented by type, application, and end user, with significant sales in various regions.
  • Price trends are expected to remain stable or decrease slightly due to the presence of generics.
  • The market forecast indicates a positive growth trajectory from 2024 to 2031.
  • Regional growth, especially in the Asia Pacific, is expected to be significant.

FAQs

What are the primary drivers of the hydrochlorothiazide market?

The primary drivers include the increasing prevalence of hypertension, growing prevalence of cardiovascular diseases, and an aging population.

Which regions are expected to see significant growth in the hydrochlorothiazide market?

North America, Europe, and the Asia Pacific are expected to see significant growth, with the Asia Pacific region being particularly promising due to increasing healthcare expenditure and improving infrastructure.

How does the presence of generics affect the hydrochlorothiazide market?

The presence of generics can reduce the average price per unit and increase sales volume but may erode the market share of branded products.

What is the forecasted CAGR for the global hydrochlorothiazide market from 2024 to 2031?

The exact CAGR is not specified in the sources, but the market is expected to grow at a significant rate driven by increasing demand.

What are the key segments covered in the hydrochlorothiazide market analysis?

The key segments include type (tablet, capsule, and liquid), application (hypertension, fluid retention, heart attack, kidney failure, and others), and end user (hospitals, drug stores, and others).

Sources

  1. Global Hydrochlorothiazide Market Recent Trends, In-depth Analysis and Forecast 2024-2031 - Global Market Vision
  2. Hydrochlorothiazide Sales, Price Analysis, & Sales Forecast 2017-2021 - ResearchAndMarkets.com
  3. Hydrochlorothiazide Market To See Incredible Growth During 2021–2030 - EIN Presswire
  4. Global Hydrochlorothiazide Market Report 2024 Edition - Cognitive Market Research
  5. Hydrochlorothiazide Prices, Coupons, Copay Cards & Patient Assistance Programs - Drugs.com

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.